First-in-kind study reveals genetic markers of type 2 diabetes in East Asians

May 06, 2020

CHAPEL HILL, NC - May 6, 2020 - In the largest study of its kind in any non-European population, an international team of researchers identified 301 distinct genetic signals at 183 loci, or specific positions on a chromosome, associated with type 2 diabetes in people from East Asia. Sixty-one of the loci were newly implicated in the predisposition for type 2 diabetes. They had not been implicated in previous genome-wide association studies (GWAS) conducted in people of European descent.

This research, published in Nature, shows how different populations of people share most of the genetic susceptibilities to developing type 2 diabetes but do have some different genetic variations that can make them more or less susceptible to developing the condition. This genome-wide meta-analysis of 433,540 East Asians, including 77,418 with type 2 diabetes, is the result of two research consortia - AGEN (Asian Genetic Epidemiology Network) and DIAMANTE (DIabetes Meta-ANalysis of Trans-Ethnic association studies).

Ultimately, the goal of such studies is to identify potential genetic targets to treat or even cure the chronic metabolic disorder that affects more than 400 million adults worldwide, according to the International Diabetes Federation.

The international team of more than 100 researchers was led by scientists at five institutions, all co-senior authors of the Nature paper:"Such a large-scale study would never have been possible without the commitment and dedication to collaboration among so many scientists around the world, especially in Asia," said Karen Mohlke of UNC-Chapel Hill. "The data this team collected and analyzed has provided the research community with much-needed new information about the biological underpinnings of diabetes."

In the new analysis of East Asian individuals, researchers used genome-wide association data from 23 cohort studies in China, South Korea, Japan, Singapore, the Philippines, Hong Kong, Taiwan, and the United States to examine type 2 diabetes risk. For example, they found new associations near genes GDAP1, PTF1A, SIX3, ALDH2, and genes that affect muscle and adipose differentiation. At another locus, researchers found two overlapping type 2 diabetes genetic signals that appear to act through two genes, NKX6-3 and ANK1, in different tissues.

"We know diabetes is caused by a complex set of risk factors, such as BMI, that have varying effects on the disease across ancestries." said Xueling Sim, of the National University of Singapore. "These findings expand the number of genetic variants associated with diabetes and highlight the importance of studying different ancestries."

Co-first author Cassandra Spracklen, PhD, assistant professor of biostatistics and epidemiology at the University of Massachusetts at Amherst School of Public Health and Health Sciences, conducted many of the analyses for the Nature paper while a postdoctoral fellow in Mohlke's lab.

"Learning about the additional variants can help identify additional genes that influence a person's risk for developing type 2 diabetes" Spracklen said. "These genes teach us more about the pathophysiology of diabetes and could ultimately become therapeutic targets."

This research could help explain why - among people of similar body mass index (BMI) or waist circumference - the prevalence of type 2 diabetes is greater in East Asian populations than in European populations.

The next steps are to combine discovery across populations and to experimentally determine which genes are altered by the genetic variants and how those alterations lead to disease.
-end-
Other first authors are Momoko Horikoshi, Young Jin Kim, and Kuang Lin.

This research was funded by more than 30 government sources and foundations including the Korea Centers for Disease Control and Prevention, Korea National Institute of Health, National Biobank of Korea, Korea Ministry of Health and Welfare, Samsung Biomedical Research Institute, National Research Foundation of Korea, National Natural Science Foundation of China, China National Center for Disease Control and Prevention, China National Institute for Nutrition and Health, National Key Research and Development Program of China, Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Atherosclerosis Prevention Foundation, Japan National Cardiovascular Research Grants, Japan Science Technology Agency, Japan Agency for Medical Research and Development, Japan National Center for Global Health and Medicine, Singapore National Medical Research Council, Singapore Biomedical Research Council, Research Grants Council of the Hong Kong Special Administrative Region, Hong Kong Foundation for Research and Development in Diabetes, Taiwan National Health Research Institutes, Taiwan National Science Council, Taiwan Taichung Veterans General Hospital, Taiwan National Center for Advancing Translational Sciences, Taiwan Academia Sinica, Philippines Office of Population Studies Foundation, United Kingdom Medical Research Council, the United States National Institutes of Health and others.

University of North Carolina Health Care

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.